Effects of Cardiovascular Medications on Rate of Functional Decline in Alzheimer Disease

Por Rosenberg, P.B., Mielke, M.M., Tschanz, J., Cook, L., Stat, M., Corcoran, Chris, Hayden, K.M., Norton, M., Rabins, P.V., Green, R.C., Welsh-Bohmer, K.A., Breitner, J.C.S., Munger, R., Lyketsos, C.G.
Publicado em 2008

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer’s disease

Por Rosenberg, P. B., Mielke, M. M., Han, D., Leoutsakos, J. S., Lyketsos, C. G., Rabins, P. V., Zandi, P. P., Breitner, J. C. S., Norton, M. C., Welsh-Bohmer, K. A., Zuckerman, I. H., Rattinger, G. B., Green, R. C., Corcoran, C., Tschanz, J. T.
Publicado em 2012